Bellerophon Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$86.8M

305 transactions

Summary

Bellerophon Therapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $57.4MSales: $8.9M63 insiders

Date	Insider	Type	Value
2023-05-18	Joint reporting: Puissance Capital Management LP; Wang Theodore T; Puissance Capital Fund (GP) LLC; Puissance Life Science Opportunities Fund VI	Sell	$5.3M
2023-06-07	Joint reporting: Puissance Capital Management LP; Wang Theodore T; Puissance Capital Fund (GP) LLC; Puissance Life Science Opportunities Fund VI	Sell	$112K
2023-10-13	Joint reporting: Puissance Capital Management LP; Wang Theodore T; Puissance Capital Fund (GP) LLC; Puissance Life Science Opportunities Fund VI	Sell	$108K
2023-05-18	Kim Bobae(VP Reg. Affairs & Quality)	Sell	$95K
2023-02-10	Bruder Scott P	A	$44K
2023-02-10	Wang Theodore T	A	$44K
2023-02-10	Cloyd Mary Ann	A	$44K
2023-05-18	Kim Bobae(VP Reg. Affairs & Quality)	M	$8K
2023-05-18	Kim Bobae(VP Reg. Affairs & Quality)	M	$2K
2023-06-07	Teufel Crispin	A	$0
2023-06-07	Cloyd Mary Ann	A	$0
2023-06-07	Wang Theodore T	A	$0
2023-06-07	Kim Bobae(VP Reg. Affairs & Quality)	A	$0
2023-06-07	Bruder Scott P	A	$0
2023-06-07	Dekker Martin(See Remarks)	A	$0
2023-06-07	Shah Parag Suresh(VP of Business Operations)	A	$0
2023-06-07	Fernandes Peter(See Remarks)	A	$0
2023-06-07	Amin Naseem	A	$0
2023-05-18	Kim Bobae(VP Reg. Affairs & Quality)	M	$0
2023-05-18	Kim Bobae(VP Reg. Affairs & Quality)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Bellerophon Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope